PACE Hospitals' Bariatric and Metabolic Surgery team successfully performed a Laparoscopic Mini Gastric Bypass, crural repair, and liver biopsy for a 27-year-old female with morbid obesity (BMI: 40.14), Polycystic Ovary Syndrome (PCOS), and insulin resistance.
A 27-year-old female patient with morbid obesity (BMI - 40.14), Polycystic Ovary Syndrome (PCOS), and bronchial asthma was presented to the consultant surgical gastroenterologist, Dr. Phani Krishna Ravula, at PACE Hospitals, Hitech City, Hyderabad.
Medical History
Delving deeper, it was understood that the patient was suffering from morbid obesity with a BMI of 40.14, polycystic ovary syndrome (PCOS), and bronchial asthma which led to her admission to PACE Hospitals for additional care and management.
Diagnosis
Upon being admitted to PACE Hospitals, and after a thorough history and physical examination, as well as evaluation of diagnostic investigations, the patient was diagnosed with morbid obesity (BMI 40.14), polycystic ovary syndrome (PCOS), and insulin resistance.
The patient has been diagnosed with morbid obesity (class III), which is a chronic, lifelong, multifactorial condition marked by excessive fat storage. This severe form of obesity is defined by a body mass index (BMI) of 40 or higher, or 35 or higher with obesity-related health consequences (hypertension, diabetes, severely limited musculoskeletal problems).
The patient also has polycystic ovarian syndrome (PCOS), which is a common hormonal problem affecting women of reproductive age. It usually begins in adolescents, but symptoms may change over time. PCOS can cause hormonal abnormalities, irregular periods, high androgen levels, and ovarian cysts. Obesity is a common cause of insulin resistance and a significant risk factor for diabetes, and it may worsen symptoms of PCOS, contributing to further weight gain and creating a cycle of metabolic dysfunction. Abnormal fat deposition in skeletal muscle has been recognized as a cause of obesity-related insulin resistance.
Treatment
After consultations with the team of surgical gastroenterologists, bariatric and metabolic surgeons - Dr. Phani Krishna Ravula, and Dr. Suresh Kumar S, it was determined that a Laparoscopic Mini Gastric Bypass procedure was the most effective method of treating the patient.
The Mini Gastric Bypass (MGB) is a type of weight loss surgery performed laparoscopically that includes a long gastric conduit, a jejunal bypass, and a broad gastro-jejunostomy (GJ), which connects the stomach directly to the lower part of the intestine to speed up digestion. To achieve this, the surgeon creates a small pouch in the stomach and redirects the small intestine so that food goes directly from the pouch to the small bowel, bypassing some of the bowel and reducing excessive calorie absorption.
This procedure results in a healthy weight and promotes good metabolism (the conversion of food into energy). In addition to treating obesity, this surgery is extremely effective at managing high blood pressure, diabetes, high cholesterol, and sleep apnea, among other conditions.
After the necessary investigations were done and clearances were obtained, the patient was administered intravenous antibiotics, and later, the Laparoscopic Mini Gastric Bypass procedure along with crural repair and liver biopsy was performed.
The stomach and liver appeared normal. The distal oesophagus had mobilized, and the crural repair has been done. A 4 cm gastric conduit was stapled from above the incisura angularis to the gastroesophageal (GE) junction. Gastrojejunostomy was performed 150 cm from the DJ flexure with staples and oversewn. A biopsy of the liver was taken. Routine liver biopsy during bariatric surgery has the advantage of detecting potential problems at an early stage. The surgical procedure was successful.
Aftermath
The post-operative period was uneventful. The patient was given intravenous antibiotics, antacids, analgesics, and IV fluids to manage any immediate post-operative needs.
Post-surgery, the patient was initiated on a liquid diet on post-operative day (POD 2), which was gradually increased to full oral liquids by POD 3. Gynecologist opinion was taken in view of polycystic ovary syndrome (PCOS). Ambulation (the ability to walk) was encouraged. The patient was tolerating well orally and was in a stable condition at discharge.
The patient was sent home with follow-up instructions and advised to follow a liquid diet as advised by the dietician including a liquid diet for one week, a puréed diet for one week, followed by a soft diet. She was advised to attend bariatric support group meetings, avoid strenuous activities for two months, and bed rest for 2 weeks.
The patient was also instructed to contact PACE Hospitals' emergency room / causality at once in case of bleeding, fever more than 101°F, wound discharge, severe pain, and altered sensorium.
After one week, the patient was asked to get a review by Dr. Phani Krishna Ravula about the status.
The Role of Obesity in Developing Insulin Resistance⚠️
Insulin is a hormone produced by β cells in the pancreas in response to food intake. Its primary role is to regulate carbohydrate, fat, and protein metabolism by increasing the absorption of blood glucose from the circulation into adipose tissue, skeletal muscle, and the liver, where it is used for energy. Excess blood glucose, on the other hand, decreases cell absorption, which eventually leads to insulin resistance and impairs the cellular insulin response. Many factors contribute to insulin resistance, including oxidative stress and reticulum stress, hereditary factors, oxygen deficiency, and lipodystrophy, which can lead to various diseases.
Insulin resistance has long been linked to obesity, which is directly related to cardiovascular illnesses such as dyslipidemia, atherosclerosis,
type 2 diabetes mellitus (T2DM), and hypertension. Obesity raises the risk of developing insulin resistance. Several inflammatory markers have been associated with an increased risk of insulin resistance in obese people.
Fill in the appointment form or call us instantly to book a confirmed appointment with our super specialist at 04048486868
Thank you for contacting us. We will get back to you as soon as possible. Kindly save these contact details in your contacts to receive calls and messages:-
Appointment Desk: 04048486868
Whatsapp: 8977889778
Regards,
Pace Hospitals
Hitech City and Madinaguda
Hyderabad, Telangana, India.
Oops, there was an error sending your message. Please try again later. We will get back to you as soon as possible. Kindly save these contact details in your contacts to receive calls and messages:-
Appointment Desk: 04048486868
Whatsapp: 8977889778
Regards,
Pace Hospitals
Hitech City and Madinaguda
Hyderabad, Telangana, India.
Metro Pillar Number C1772, Beside Avasa Hotel, Hitech City Road, Near HITEC City Metro Station, Hyderabad, Telangana, India.
Mythri Nagar, Beside South India Shopping Mall, Hafeezpet, Madeenaguda, Hyderabad, Telangana, India.
040 4848 6868
Payment in advance for treatment at PACE Hospitals, Hyderabad, Telangana, India (Pay in INR ₹)
For Bank Transfer:-
Scan QR Code by Any Payment App (GPay, Paytm, Phonepe, BHIM, Bank Apps, Amazon, Airtel, Truecaller, Idea, Whatsapp etc).
Thank you for subscribing to PACE Hospitals' Newsletter. Stay updated with the latest health information.
Oops, there was an error. Please try again submitting your details.
Disclaimer
General information on healthcare issues is made available by PACE Hospitals through this website (www.pacehospital.com), as well as its other websites and branded social media pages. The text, videos, illustrations, photographs, quoted information, and other materials found on these websites (here by collectively referred to as "Content") are offered for informational purposes only and is neither exhaustive nor complete. Prior to forming a decision in regard to your health, consult your doctor or any another healthcare professional. PACE Hospitals does not have an obligation to update or modify the "Content" or to explain or resolve any inconsistencies therein.
The "Content" from the website of PACE Hospitals or from its branded social media pages might include any adult explicit "Content" which is deemed exclusively medical or health-related and not otherwise. Publishing material or making references to specific sources, such as to any particular therapies, goods, drugs, practises, doctors, nurses, other healthcare professionals, diagnoses or procedures is done purely for informational purposes and does not reflect any endorsement by PACE Hospitals as such.